Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5265)
Addus HomeCare Corp (ADUS)
TUCKER DAVID W. — EVP, Chief Strategy Officer
Shares
379
Price
$105.36
Total Value
$39.93K
Shares Held After
10,423
% of Holdings
3.5%
INSULET CORP (PODD)
MINOGUE MICHAEL R — Director
Shares
2,030
Price
$246.23
Total Value
$499.85K
Shares Held After
17,483
% of Holdings
11.6%
Arcellx, Inc. (ACLX)
Gilson Michelle — CHIEF FINANCIAL OFFICER
Shares
11,219
Price
$113.82
Total Value
$1.28M
Shares Held After
33,938
% of Holdings
24.8%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
8
Price
$93.49
Total Value
$747.92
Shares Held After
666,195
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
1,501
Price
$92.81
Total Value
$139.31K
Shares Held After
666,203
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
3,293
Price
$91.76
Total Value
$302.17K
Shares Held After
667,704
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
5,434
Price
$90.39
Total Value
$491.18K
Shares Held After
670,997
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
19,764
Price
$89.78
Total Value
$1.77M
Shares Held After
676,431
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
CAUSEY CHRISTOPHER — Director
Shares
1,000
Price
$520.00
Total Value
$520.00K
Shares Held After
4,190
% of Holdings
19.3%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
3,161
Price
$36.46
Total Value
$115.25K
Shares Held After
459,859
% of Holdings
0.7%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
61,547
Price
$36.13
Total Value
$2.22M
Shares Held After
463,020
% of Holdings
11.7%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
1,151
Price
$51.88
Total Value
$59.71K
Shares Held After
15,560
% of Holdings
6.9%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
5,889
Price
$51.27
Total Value
$301.92K
Shares Held After
16,711
% of Holdings
26.1%
EXELIXIS, INC. (EXEL)
Aftab Dana — EVP, Research and Development
Shares
47,918
Price
$44.50
Total Value
$2.13M
Shares Held After
616,106
% of Holdings
7.2%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
2,425
Price
$274.90
Total Value
$666.63K
Shares Held After
93,537
% of Holdings
2.5%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
930
Price
$269.50
Total Value
$250.64K
Shares Held After
95,962
% of Holdings
1.0%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
1,674
Price
$268.67
Total Value
$449.75K
Shares Held After
96,892
% of Holdings
1.7%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
1,891
Price
$267.37
Total Value
$505.60K
Shares Held After
98,566
% of Holdings
1.9%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
4,339
Price
$266.62
Total Value
$1.16M
Shares Held After
100,457
% of Holdings
4.1%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
1,604
Price
$265.54
Total Value
$425.92K
Shares Held After
104,796
% of Holdings
1.5%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
900
Price
$264.60
Total Value
$238.14K
Shares Held After
106,400
% of Holdings
0.8%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
62
Price
$263.05
Total Value
$16.31K
Shares Held After
107,300
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
373
Price
$271.09
Total Value
$101.12K
Shares Held After
0
% of Holdings
100.0%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
370
Price
$269.83
Total Value
$99.84K
Shares Held After
373
% of Holdings
49.8%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
3,963
Price
$268.97
Total Value
$1.07M
Shares Held After
743
% of Holdings
84.2%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
6,671
Price
$268.04
Total Value
$1.79M
Shares Held After
4,706
% of Holdings
58.6%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
11,673
Price
$266.97
Total Value
$3.12M
Shares Held After
11,377
% of Holdings
50.6%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
8,986
Price
$266.18
Total Value
$2.39M
Shares Held After
23,050
% of Holdings
28.0%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
3,557
Price
$265.08
Total Value
$942.88K
Shares Held After
32,036
% of Holdings
10.0%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
1,733
Price
$264.12
Total Value
$457.73K
Shares Held After
35,593
% of Holdings
4.6%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
569
Price
$262.91
Total Value
$149.59K
Shares Held After
37,326
% of Holdings
1.5%
Addus HomeCare Corp (ADUS)
BLESSING CLIFF DONALD — EVP, Chief Development Officer
Shares
350
Price
$107.14
Total Value
$37.50K
Shares Held After
12,538
% of Holdings
2.7%
Addus HomeCare Corp (ADUS)
Anderson Darby — EVP, Chief Govt Rel Officer
Shares
733
Price
$106.98
Total Value
$78.42K
Shares Held After
46,642
% of Holdings
1.5%
Addus HomeCare Corp (ADUS)
Stevenson Roberton James — EVP, Chief HR Officer
Shares
567
Price
$107.35
Total Value
$60.87K
Shares Held After
14,314
% of Holdings
3.8%
Addus HomeCare Corp (ADUS)
WATTENBARGER MICHAEL D. — EVP, Chief Information Officer
Shares
592
Price
$107.35
Total Value
$63.55K
Shares Held After
9,744
% of Holdings
5.7%
Addus HomeCare Corp (ADUS)
RAINES MONICA — EVP, CCO and Quality Officer
Shares
437
Price
$106.99
Total Value
$46.75K
Shares Held After
14,020
% of Holdings
3.0%
Addus HomeCare Corp (ADUS)
TUCKER DAVID W. — EVP, Chief Strategy Officer
Shares
704
Price
$107.35
Total Value
$75.57K
Shares Held After
10,802
% of Holdings
6.1%
Voyager Therapeutics, Inc. (VYGR)
Carter Todd Alfred — Chief Scientific Officer
Shares
4,174
Price
$3.76
Total Value
$15.69K
Shares Held After
145,718
% of Holdings
2.8%
Voyager Therapeutics, Inc. (VYGR)
Swartz Robin — COO & CBO
Shares
6,458
Price
$3.77
Total Value
$24.35K
Shares Held After
199,738
% of Holdings
3.1%
Voyager Therapeutics, Inc. (VYGR)
Sandrock Alfred — Director
Shares
14,197
Price
$3.79
Total Value
$53.81K
Shares Held After
484,060
% of Holdings
2.8%
Voyager Therapeutics, Inc. (VYGR)
Jorgensen Nathan D. — Chief Financial Officer
Shares
4,668
Price
$3.77
Total Value
$17.60K
Shares Held After
151,416
% of Holdings
3.0%
LABCORP HOLDINGS INC. (LH)
Caveney Brian J — EVP, Pres of ED, CMO & CSO
Shares
1,500
Price
$286.31
Total Value
$429.46K
Shares Held After
30,107
% of Holdings
4.7%
EXAGEN INC. (XGN)
Black Jeffrey G. — Chief Financial Officer
Shares
1,584
Price
$3.61
Total Value
$5.72K
Shares Held After
267,442
% of Holdings
0.6%
EXAGEN INC. (XGN)
ABALLI JOHN — Director
Shares
11,430
Price
$3.61
Total Value
$41.26K
Shares Held After
702,997
% of Holdings
1.6%
CODEXIS, INC. (CDXS)
Lutz Stefan — Chief Scientific Officer
Shares
5,862
Price
$1.13
Total Value
$6.64K
Shares Held After
130,421
% of Holdings
4.3%
iRhythm Holdings, Inc. (IRTC)
Rosenbaum Marc Wade — Chief Accounting Officer
Shares
280
Price
$140.91
Total Value
$39.45K
Shares Held After
10,601
% of Holdings
2.6%
iRhythm Holdings, Inc. (IRTC)
Smith Mervin — EVP Strategic Business Ops
Shares
732
Price
$140.91
Total Value
$103.15K
Shares Held After
15,106
% of Holdings
4.6%
ARTIVION, INC. (AORT)
Davis John E — Chief Commercial Officer
Shares
2,075
Price
$35.69
Total Value
$74.06K
Shares Held After
188,868
% of Holdings
1.1%
ARTIVION, INC. (AORT)
Horton Amy — VP, Chief Accounting Officer
Shares
830
Price
$35.69
Total Value
$29.63K
Shares Held After
127,497
% of Holdings
0.6%
ARTIVION, INC. (AORT)
Stanton Marshall S. — SVP, Clinical & MD Affair
Shares
1,259
Price
$35.69
Total Value
$44.94K
Shares Held After
41,921
% of Holdings
2.9%
Showing 2351–2400 of 5265 transactions (page 48 of 106)